Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allantoin is a naturally occurring diureide of glyoxylic acid, produced via the oxidation of uric acid. It is widely utilized in dermatology and wound care for its keratolytic, emollient, and skin-soothing properties. By softening keratin and increasing the water content of the extracellular matrix, allantoin promotes skin desquamation and stimulates epithelial cell regeneration. It is frequently formulated in topical shampoos, creams, and solutions, often in combination with agents like coal tar, clioquinol, or dexamethasone. Beyond topical use, it has been investigated in combination therapies (e.g., DAM solution) for systemic or internal applications such as the treatment of post-operative ileus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on allantoin (Laboratorios Silanes).